|
|||||
|
|
Expression of CD30 as a biomarker to predict response to brentuximab vedotin |
|
| Authors: | Mina L Xu Carlos Acevedo‐Gadea Stuart Seropian Samuel G Katz |
| Affiliation: | 1. Department of Pathology, Yale Cancer Center, Smilow Cancer Hospital of the Yale‐New Haven Hospital, Yale University School of Medicine, New Haven, CT, USA;2. Division of Hematology, Yale Cancer Center, Smilow Cancer Hospital of the Yale‐New Haven Hospital, Yale University School of Medicine, New Haven, CT, USA |
| Abstract: | |
| Keywords: | |